FDA.reportPublic FDA data

pacritinib 100 MG Oral Capsule [Vonjo]

RxCUI
2595254
RxNorm name
pacritinib 100 MG Oral Capsule [Vonjo]
Display name
pacritinib 100 MG Oral Capsule [Vonjo]
Full name
pacritinib 100 MG Oral Capsule [Vonjo]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VonjoPACRITINIBSobi, Inc.4b5ab444-0e1a-4984-99db-76ad11a298ee2026-07-30Warnings, Adverse reactionsExact identifier
rxcui: 2595254

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4b5ab444-0e1a-4984-99db-76ad11a298eeVONJO 100 MG Oral Capsule [PSN] · pacritinib 100 MG Oral Capsule [Vonjo] [SBD] · Vonjo 100 MG Oral Capsule [SY]39These highlights do not include all the information needed to use VONJO safely and effectively. See full prescribing information for VONJO. VONJO ® (pacritinib) capsules, for oral use Initial U.S. Approval: 202220260325